Augusta University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Augusta University sits in the top decile of US sponsors by registered trial count (#231 of 15,742 sponsors by registered trial count).
Augusta University: 106 sponsored US clinical trials, 13 recruiting.
Augusta University sponsors 106 registered US clinical trials on ClinicalTrials.gov, 13 of them currently recruiting, and 71 completed. 11 of these trials are in Phase 3-4 (later-stage) and 23 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 4 trials.
Top-decile sponsor footprint
Augusta University ranks in the top decile of sponsors by registered trial count (#231 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
71 of 83 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
106 total, page 2 of 3
Anesthetic and Obstetric Outcomes in Morbidly Obese Pregnancy and Cesarean Delivery
NCT03590951
Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens
NCT02635984
Home Versus Office Biofeedback Therapy for Fecal Incontinence
NCT03216291
Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
NCT02774226
The Role of Endothelin-1 in Sickle Cell Disease
NCT02712346
Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress
NCT02431936
Neuromodulation Therapy for Fecal Incontinence
NCT02556151
Mental Activity During (TMS) Therapy for Depression
NCT03701932
Low Pulse Amplitude Focal ECT (LAP Study)
NCT02583490
Longitudinal Assessment of Exercise Capacity and Vascular Function in Patients With CF
NCT03338595
Blood Flow and Vascular Function in Cystic Fibrosis
NCT02057458
Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD)
NCT02199652
Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients
NCT02078323
A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients
NCT01805895
Reducing Suicidal Ideation Through Insomnia Treatment
NCT01689909
Gemcitabine and CT-011 for Resected Pancreatic Cancer
NCT01313416
Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer
NCT01420965
Role of Infected Blood Dendritic Cells in Heart Disease Risk
NCT01568944
Vitamin D Supplementation in Overweight/Obese African American Adults and Youth (D-SUNNY)
NCT01583621
Clinical Utility of Breath Tests in GI
NCT03261856
Cystic Fibrosis and Endothelial Function: At Rest and During Exercise
NCT01772758
Clinical Evaluation of Polarized Light Assisted Colposcopy
NCT01349621
Green Tea Lozenges for the Management of Dry Mouth
NCT01647737
Vitamin and Asthma Study
NCT01447173
Investigation of Supra Fiber in the Treatment of Adults With Constipation
NCT01288508
Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD)
NCT01398943
Prevention of Traumatic Brain Injury in Youth and Adolescents
NCT01629121
Caregivers' Knowledge of Emergency Department Discharge Instructions Improves With the Use of Video
NCT01630265
MAPP Investigation of Pelvic Floor-Brain Neurobiologic Axis in IC/IBS and IBS
NCT01280864
The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults
NCT01141192
Topical Bethanechol for Improvement of Esophageal Dysmotility
NCT01031043
Lifestyle Change to Prevent Diabetes Via African-American Churches
NCT01730196
An Open Trial of Cysteamine Treatment in Schizophrenia
NCT01139125
Promoting Asthma Wellness in Rural Communities
NCT01170676
Investigation of Dietary Absorptive Capacity of Fructans in Healthy Subjects - A Dose Response Study
NCT00988403
Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation.
NCT01190020
Vitamin D Supplement Study for Adolescents
NCT00909454
Randomized Control Trial of L-Alanine and Placebo in Fructose Intolerance
NCT01288495
Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in Children
NCT02383485
Exercise & Overweight Children's Cognition
NCT02227095
Efficacy of Lubiprostone in Combination With Standard PEG Preparation
NCT00689026
Sierra High Definition Ano-Rectal Manometry
NCT01300884
SAT vs Escitalopram for Rectal Hypersensitivity
NCT00584571
GenTeal in Perioperative Treatment of Laser Assisted in Situ Keratomileusis LASIK Patients
NCT00598689
Using an Electronic Personal Health Record to Empower Patients With Hypertension
NCT01317537
The Impact of a Tobacco Control Intervention in African-American Families
NCT01164306
Evaluating the Relationship Between Inflammation, Genetics, and Stress in the Development of High Blood Pressure
NCT00384241
Genetic Study of Liver Enzymes in Patients With Side Effects From Antidepressants
NCT00360256
SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole
NCT00344994
Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids
NCT00211562
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 13 |
| Phase 2 | 10 |
| Phase 3 | 4 |
| Phase 4 | 7 |
Therapeutic Areas
What is open in the Augusta University pipeline
13 recruiting of 106 indexed (12% open); 71 completed (67%).
Phase mix: 11 late (III/IV) vs 23 early (I/II) (early-phase heavy).
Top condition: Hypertension (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Augusta University: open-pipeline peers nationwide
Peers matched on 106 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Augusta University sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 106 trials (± recruiting share)
- Corewell Health East · 106 trials · 9% recruiting
- University of Delaware · 106 trials · 23% recruiting
- Geisinger Clinic · 107 trials · 9% recruiting
- St. Louis University · 107 trials · 11% recruiting
Sponsors near 12% open enrollment (± trial volume)
- University of Iowa · 12% recruiting · 228 trials
- National Institute of Mental Health (NIMH) · 12% recruiting · 343 trials
- Daiichi Sankyo · 12% recruiting · 236 trials
- Friends Research Institute · 12% recruiting · 41 trials
Related
What to do with this Augusta University page
106 registered trials is a research-attention snapshot, not an endorsement of Augusta University or any single study.
- 13 of Augusta University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Augusta University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Augusta University pipeline card: 106 registered trials from official public datasets.Report a data error.